Unique ID issued by UMIN | UMIN000040658 |
---|---|
Receipt number | R000046409 |
Scientific Title | Effects of high intensity interval walking training on muscle strength in dynapenic patients with diabetes. |
Date of disclosure of the study information | 2020/09/01 |
Last modified on | 2024/04/08 13:30:59 |
Effects of high intensity interval walking training on dynapenia
Effects of high intensity interval walking training on dynapenia
Effects of high intensity interval walking training on muscle strength in dynapenic patients with diabetes.
Effects of high intensity interval walking training on muscle strength in dynapenic patients with diabetes.
Japan |
Type1 and Type 2 Diabetes
Endocrinology and Metabolism |
Others
NO
The aim of this study is to evaluate the effects of high intensity interval walking training on increasing muscle strength in dyanapenic patients with diabetes using a randomized controlled design.
Safety,Efficacy
Knee extension strength
The differences in outcome variables, measured in the pre-, middle (3-mounths), and post-intervention (5-months) periods.
Secondary outcome: gait speed, VO2 peak, Health related QOL,
Other outcome: BMI, skeletal muscle mass index, grip strength, fall risk index, mini nutritional assessment, HbA1c, eGFR, physical activity, skin autofluorescence, urinary albumin, nutrition intake.
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
2
Treatment
Behavior,custom |
High intensity interval walking training(combined with fast walking at 70% or more of estimated maximum oxygen intake and slow walking at 40%in 3 minutes each) for 5 months(more than 120 minute-interval per week).
Usual walking for 5 months (more than 120 minutes per week).
30 | years-old | <= |
80 | years-old | > |
Male and Female
the patients with type 1 and type 2 diabetes, who are able to exercise at 70% intensity of peak heart rate
People with cardiac pacemaker
People with joint pain and movement restriction at the knee and waist.
People in another clinical study, within 2 months prior to the start of this study
People who are unable to continue the intervention
People treated with severe peripheral neuropathy, retinopathy, chronic kidney disease, or cardiovascular disease.
50
1st name | Munehide |
Middle name | |
Last name | Matsuhisa |
Tokushima University
Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences
770-8011
3-18-15, Kuramoto-cho, Tokushima
088-633-7587
matuhisa@tokushima-u.ac.jp
1st name | Hiroyasu |
Middle name | |
Last name | Mori |
Tokushima University
Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences
770-8503
3-18-15, Kuramoto-cho, Tokushima
088-633-7587
mori.hiroyasu@tokushima-u.ac.jp
Tokushima University
Japan Association for Diabetes Education and Care
Other
Clinical Trial Center for Developmental therapeutics, Tokushima University Hospital
2-50-1 Kuramoto, Tokushima
0886339347
awachiken@tokushima-u.ac.jp
NO
2020 | Year | 09 | Month | 01 | Day |
Unpublished
No longer recruiting
2020 | Year | 06 | Month | 05 | Day |
2023 | Year | 01 | Month | 30 | Day |
2022 | Year | 07 | Month | 01 | Day |
2025 | Year | 02 | Month | 28 | Day |
2020 | Year | 06 | Month | 05 | Day |
2024 | Year | 04 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046409
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |